Rami Katkhuda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rami katkhuda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rami Katkhuda Today - Breaking & Trending Today

Inventiva S.A. (NASDAQ:IVA) Q4 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Inventiva Annual Results 2023 conference call. At this time, all participants are in a listen-only mode. ....

South Korea , United States , Steve Harrison , Sino Biopharm , Pierre Broqua , Seamus Fernandez , Jean Volatier , European Investment Bank , Valuerich Inc , Qatar Holding , University Of Florida , Call Transcript March , Inventiva Annual Results , Private Securities Litigation Reform Act , Co Founder Pierre , Professor Cusi , North America , Yiheng Capital , Industrial Machinery Stocks , Rami Katkhuda ,

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Q1 2023 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen and welcome to Eledon Pharmaceuticals first quarter 2023 earnings conference call. At this time, all lines are listen-only mode. ....

United Kingdom , United States , David Alexandre Gros , Thomas Smith , Steve Perrin , Vernon Bernardino , Matt Kaplan , Jeff Bornstein , Pete Stavropoulos , Paul Little , Exchange Commission , Eledon Pharmaceuticals , Eledon Pharmaceuticals Inc , National Kidney Foundation , Cantor Fitzgerald , World Congress , Ladenburg Thalmann , United Network For Organ , Call Transcript May , Chief Executive Officer , Chief Scientific , Chief Medical Officer , Private Securities Litigation Reform Act , Safe Harbor , Alexandre Gros , United Network ,

Viridian Therapeutics, Inc. (VRDN) CEO Jonathan Violin on Q1 2022 Results - Earnings Call Transcript

Viridian Therapeutics, Inc. (NASDAQ:NASDAQ:VRDN) Q1 2022 Earnings Conference Call May 12, 2022, 16:30 ET Company Participants John Jordan - VP, Investor Relations and Corporate. ....

Christopher Howerton , Laura Chico , Chris Howerton , Jason Butler , Thomas Smith , John Jordan , Kristian Humer , Company Participants , Corporate Communications , Corporate Communications At Viridian , Viridian Therapeutics Inc , Viridian Therapeutics , Conference Call May , Investor Relations , Chief Business Officer , Principal Financial Officer , Principal Accounting , Viridian Therapeutics First Quarter , Vice President , Jonathan Violin , Chief Executive Officer , Chief Financial Officer , Chief Business , Thyroid Eye Disease , Thyroid Eye , Rami Katkhuda ,

Eledon Pharmaceuticals, Inc's (ELDN) CEO David-Alexandre Gros on Q1 2022 Results - Earnings Call Transcript

Eledon Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ELDN) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Paul Little – Chief Financial Officer David-Alexandre Gros –. ....

United Kingdom , Jeff Bornstein , Matt Kaplan , Nat Charoensook , Paul Little , David Alexandre Gros , Steve Perrin , Pete Stavropoulos , Tom Smith , Exchange Commission , Company Participants , Cantor Fitzgerald , Ladenburg Thalmann , Eledon Pharmaceuticals Inc , Eledon Pharmaceuticals , Conference Call May , Chief Financial , Alexandre Gros , Chief Executive , Chief Scientific , Chief Medical , Chief Financial Officer , Chief Executive Officer , Chief Scientific Officer , Private Securities Litigation Reform Act , Rating Scale ,